Luminate eye gel
The present invention features novel cosmetic skin care compositions for improving the appearance of skin, particularly the periocular region.
1. A cosmetic composition for topical application comprising:
dimethylmethoxy chromanyl palmitate at a concentration of from 0.05-0.5%; palmitoyl tripeptide-1 at a concentration of from 0.0001-0.001%; palmitoyl tetrapeptide-7 at a concentration of from 0.0001-0.0005%; and
a cosmetically acceptable vehicle.
2. The composition of claim 1 , further comprising chrysin at a concentration of from 0.0001-0.001%.
3. The composition of claim 2 , further comprising N-hydroxysuccinimide at a concentration of from 0.001-0.01%.
4. The composition of claim 3 , further comprising linoleic acid at a concentration of from 0.1-1%; linolenic acid at a concentration of from 0.05-0.25%; tocopherol acetate at a concentration of from 0.1-1%; retinol at a concentration of from 0.01-0.075%; and ceramide-2 at a concentration of from 0.001-0.01%.
5. The composition of claim 4 , wherein the cosmetically acceptable vehicle is a gel.
6. The composition of claim 5 , wherein the gel is comprised of a mixture of cyclic siloxanes.
7. The composition of claim 6 , wherein the cyclic siloxanes comprise from 75% to about 85% of the cosmetic composition.
8. The composition of claim 4 , comprising by weight:
dimethylmethoxy chromanyl palmitate at a concentration of 0.1%; palmitoyl tripeptide-1 at a concentration of about 0.0002%; palmitoyl tetrapeptide-7 at a concentration of 0.0001%; chrysin at a concentration of 0.0002%; N-hydroxysuccinimide at a concentration of 0.004%; linoleic acid at a concentration of 0.4%; linolenic acid at a concentration of 0.1%; tocopherol acetate at a concentration of 0.5%; retinol at a concentration of 0.03%; and ceramide-2 at a concentration of 0.002%.
9. A method of improving the appearance of the skin of the periocular area, comprising:
topically applying a cosmetic composition comprising:
dimethylmethoxy chromanyl palmitate at a concentration of from 0.05-0.5%; palmitoyl tripeptide-1 at a concentration of from 0.0001-0.001%; palmitoyl tetrapeptide-7 at a concentration of from 0.0001-0.0005%; and
a cosmetically acceptable vehicle.
10. The method of claim 9 , wherein the composition further comprises chrysin at a concentration of from 0.0001-0.001%.
11. The method of claim 10 , wherein the composition further comprises N-hydroxysuccinimide at a concentration of from 0.001-0.01%.
12. The method of claim 11 , wherein the composition further comprises linoleic acid at a concentration of from 0.1-1%; linolenic acid at a concentration of from 0.05-0.25%; tocopherol acetate at a concentration of from 0.1-1%; retinol at a concentration of from 0.01-0.075%; and ceramide-2 at a concentration of from 0.001-0.01%.
13. The method of claim 9 , wherein the cosmetically acceptable vehicle is a gel.
14. The method of claim 13 , wherein the gel is comprised of a mixture of cyclic siloxanes.
15. The method of claim 14 , wherein the cyclic siloxanes comprise from 75% to about 85% of the cosmetic composition.
16. The method of claim 9 , wherein the composition further comprises by weight:
dimethylmethoxy chromanyl palmitate at a concentration of 0.1%; palmitoyl tripeptide-1 at a concentration of 0.0002%; palmitoyl tetrapeptide-7 at a concentration of 0.0001%; chrysin at a concentration of 0.0002%; N-hydroxysuccinimide at a concentration of 0.004%; linoleic acid at a concentration of 0.4%; linolenic acid at a concentration of 0.1%; tocopherol acetate at a concentration of 0.5%; retinol at a concentration of 0.03%; and ceramide-2 at a concentration of 0.002%.